Cohort study of predictive value of urinary albumin excretion for atherosclerotic vascular disease in patients with insulin dependent diabetes

British Medical Journal

Volumn 312, Issue 7035, 1996, Pages 871-874

  Deckert, Torsten ^a   Yokoyama, Hiroki ^a   Mathiesen, Elisabeth ^a   Rønn, Birgitte ^a   Jensen, Tonny ^a   Feldt Rasmussen, Bo ^a   Borch Johnsen, Knut ^a   Jensen, Jan Skov ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; SIALIC ACID; VON WILLEBRAND FACTOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; DEATH CERTIFICATE; DENMARK; DIABETIC NEPHROPATHY; FEMALE; FOLLOW UP; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PRIORITY JOURNAL; PROTEINURIA; QUESTIONNAIRE; RISK FACTOR; SMOKING HABIT;

EID: 0029947452     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.312.7035.871     Document Type: Article

References (46)

1. Morrish NJ, Stevens LK, Head J, Fuller JH, Jarrett RJ, Keen H. A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO multinational study of vascular disease in diabetics). I: Causes and death rates. Diabetologia 1990;33:538-41.
2. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T. Coronary heart disease in young type 1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 1987;30:144-8.
3. Borch-Johnsen K, Kreiner S. Proteinuria - value as predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. BMJ 1987;294: 1561-4.
4. Messent JWC, Elliot TG, Hill RD, Jarrett RJ, Keen H, Viberti GC. Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: a twenty-three year follow-up study. Kidney Int 1992;41:836-9.
5. Torffvit O, Agardh C-D. The predictive value of albuminuria for cardiovascular and renal disease. A 5-year follow-up study of 476 patients with type 1 diabetes mellitus. J Diabetes Complications 1993;7:49-56.
6. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrels TJ. Microalbuminuria predicts mortality in non-insulin-dependent diabetes. Diabet Med 1984;1:17-9.
7. Schmitz A, Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet Med 1988;5:1126-34.
8. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990;300: 297-300.
9. Damsgaard EM, Frøland A, Jørgensen OD, Mogensen CE. Eight to nine year mortality in known non-insulin dependent diabetics and controls. Kidney Int 1992;41:731-5.
10. Mattock MB, Morrish NJ, Viberti GC, Keen H, Fitzgerald AP, Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes 1992;41:736-41.
11. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care 1993;16:996-1003.
12. Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet 1988;ii:530-3.
13. Mathiesen ER, Oxenbøll B, Johansen K, Svendsen PA, Deckert T. Incipient nephropathy in type 1 (insulin-dependent) diabetes. Diabetologia 1984;26: 406-10.
14. Wiseman M, Viberti GC, Mackintosh D, Jarrett RJ, Keen H. Glycaemia, arterial pressure and microalbuminuria in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1984;26:401-5.
15. Jensen T, Stender S, Deckert T. Abnormalities in plasma concentrations of lipoproteins and fibrinogen in Type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion. Diabetologia 1988;31:142-5.
16. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC. Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. BMJ 1989;298:487-90.
17. Telmer S, Christiansen JS, Andersen AR, Nerup J, Deckert T. Smoking habits and prevalence of clinical diabetic microangiopathy in insulin-dependent diabetics. Acta Med Scand 1984;215:63-8.
18. Chase HP, Garg SK, Marshall G, Berg CL, Harris S, Jackson WE, et al. Cigarette smoking increases the risk of albuminuria among subjects with type 1 diabetes. JAMA 1991;265:614-7.
19. Feldt-Rasmussen B, Mathiesen ER, Deckert T. Effect of two years of strict metabolic control on progression of incipient nephropathy in insulin-dependent diabetes. Lancet 1986;ii:1300-4.
20. Feldt-Rasmussen B, Mathiesen ER, Deckert T, Giese J, Christensen NJ, Bent-Hansen I, et al. Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987;30: 610-7.
21. Jensen T, Stender S, Goldstein K, Hølmer G, Deckert T. Partial normalization by dietary cod-liver oil of increased microvascular albumin leakage in patients with insulin-dependent diabetes and albuminuria. N Engl J Med 1989;321:1572-7.
22. Jensen T. Increased plasma von Willebrand factor in insulin dependent diabetic patients with incipient nephropathy. BMJ 1989;298:27-8.
23. Jensen T, Bjerre-Knudsen J, Feldt-Rasmussen B, Deckert T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet 1989;i:461-3.
24. Mathiesen ER, Rønn B, Jensen T, Storm B, Deckert T. The relationship between blood pressure and urinary albumin excretion in the development of microalbuminuria. Diabetes 1990;39:245-9.
25. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 1965;2:235-9.
26. Feldt-Rasmussen B, Mathiesen ER. Variability of urinary albumin excretion in incipient diabetic nephropathy. Diabetic Nephropathy 1984;3:101-3.
27. Jensen T, Stender S, Deckert M. Comparison of ultracentrifugation and a precipitation method for high-density lipoprotein cholesterol quantitation in insulin-dependent diabetic patients. Scand J Clin Lab Invest 1989;49: 589-93.
28. Simpson H, Chusney GD, Crook MA, Pickup JC. Serum sialic acid enzymatic assay based on microtitre plates: application for measuring capillary serum sialic acid concentrations. Br J Biomed Sci 1993;50:164-7.
29. Ingerslev J. A sensitive ELISA for von Willebrand factor (vWf:Ag). Scand J Clin Lab Invest 1987;47:143-9.
30. 1c. induced by short-term changes in glucose concentration. Diabetologia 1980;19:130-6.
31. Rose GA. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ 1962;27:546-58.
32. Schroll M. A ten-year prospective study, 1964-1974, of cardiovascular risk factors in men and women from the Glostrup population born in 1914. Dan Med Bull 1982;29:213-52.
33. Jensen G. Epidemiology of chest pain and angina pectoris - with special reference to treatment needs. Acta Med Scand 1983;214(suppl 682):1-120.
34. Borch-Johnsen K, Andersen PK, Deckert T. The effect of proteinuria on relative mortality in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1985;8:590-6.
35. Parving H-H, Hommel E, Mathiesen ER, Skøtt P, Edsberg B, Bahnsen M, et al. Prevalence of microalbuminuria, arterial hypertension, retinopathy and neuropathy in insulin-dependent diabetic patients. BMJ 1988;296: 156-60.
36. Nørgaard K, Feldt-Rasmussen B, Borch-Johnsen K, Sælan H, Deckert T. Prevalence of hypertension in Type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1990;33:407-10.
37. Crook MA, Earle K, Morocutti A, Yip J, Viberti GC, Pickup JC. Serum sialic acid, a risk factor for cardiovascular disease, is increased in IDDM patients with microalbuminuria and clinical proteinuria. Diabetes Care 1994;17: 305-10.
38. Yokoyama H, Jensen JS, Jensen T, Deckert T. Serum sialic acid concentration is elevated in IDDM especially in early diabetic nephropathy. J Intern Med 1995;237:519-23.
39. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage. The Steno hypothesis. Diabetologia 1989;32:219-26.
40. Deckert T, Jensen T, Feldt-Rasmussen B, Kofoed-Enevoldsen A, Borch-Johnsen K, Stender S. Albuminuria a risk marker of atherosclerosis in insulin dependent diabetes mellitus. Cardiovascular Risk Factors 1991;1: 154-8.
41. Lindberg G, Eklund GA, Gullberg B, Rastam L. Serum sialic acid concentration and cardiovascular mortality. BMJ 1991;302:143-6.
42. Schauer R. Chemistry, metabolism, and biological functions of sialic acids. Adv Carbohydr Chem Biochem 1982;40:131-234.
43. Castello M, Barry A, Fiedel BA, Gewurz H. Inhibition of platelet aggregation by native and desialised alpha-1 acid glycoprotein. Nature 1979;281:677-8.
44. Schnitzer JE, Pinney E. Quantitation of specific binding of orosomucoid to cultured microvascular endothelium: role in capillary permeability. Am J Physiol 1992;32:H48-55.
45. Orekhov AN, Tenov VV, Mukhin DN. Desialylated low density lipoprotein - naturally occuring modified lipoprotein with atherogenic potency. Atherosclerosis 1991;86:153-61.
46. Jarrett RJ. Cardiovascular disease and hypertension in diabetes mellitus. Diabetes Metab Rev 1989;5:547-58.